Efficacy and safety of prostaglandin f-2-alpha as an abortifacient.
D000028:Abortion, Induced; D000650:Amnion; D003967:Diarrhea / Q000139:chemically induced; D004341:Drug Evaluation; D004562:Electrocardiography; D005260:Female; D005865:Gestational Age; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D007962:Leukocytes / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects; D010298:Parity; D011247:Pregnancy; D011453:Prostaglandins / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D013268:Stimulation, Chemical; D013997:Time Factors; D014592:Uterine Hemorrhage; D014599:Uterus / Q000187:drug effects; D014839:Vomiting / Q000139:chemically induced
D011453:Prostaglandins